Literature DB >> 30063426

Prognostic indicators for papillary thyroid carcinoma.

Fabio Maino1, Raffaella Forleo1, Furio Pacini1.   

Abstract

INTRODUCTION: Differentiated thyroid cancer (DTC) includes more than 90% of all thyroid carcinoma and its incidence is growing, mainly due to an increase in the incidence of papillary thyroid cancer (PTC) for the widespread use of neck ultrasonography. Areas covered: Several prognostic factors should be considered during the management of PTC in order to provide the most effective treatment. The most important prognostic factors in PTC include personal and pathological features such as patient's age, gender, hystotype, tumor size, extrathyroidal extension, lymph node involvement, presence of local or distant metastases and molecular analyses. We performed a search in the PubMed database for studies published in English since 1960 using the terms: 'thyroid cancer', 'prognostic factors', 'age', 'gender', 'hystotype', 'tumor size', 'extrathyroidal extension', 'lymph node', 'metastases' and 'molecular analyses'. Expert commentary: Prognostic factors can guide clinicians during the treatment and follow-up of DTC patients, but it is now evident that the risk of recurrence or death must be evaluated periodically, on the basis of individual risk, according to the response to initial therapy or the subsequent therapy required during follow-up.

Entities:  

Keywords:  Differentiated thyroid cancer; age; extrathyroidal extension; gender; hystotype; lymph node; metastases; molecular analyses; prognostic factors; tumor size

Year:  2017        PMID: 30063426     DOI: 10.1080/17446651.2017.1309278

Source DB:  PubMed          Journal:  Expert Rev Endocrinol Metab        ISSN: 1744-6651


  2 in total

1.  Nomogram for Predicting Central Lymph Node Metastasis in Papillary Thyroid Cancer: A Retrospective Cohort Study of Two Clinical Centers.

Authors:  Zheyu Yang; Yu Heng; Jianwei Lin; Chenghao Lu; Dingye Yu; Lei Tao; Wei Cai
Journal:  Cancer Res Treat       Date:  2020-06-09       Impact factor: 4.679

2.  Papillary Thyroid Carcinoma Tissue miR-146b, -21, -221, -222, -181b Expression in Relation with Clinicopathological Features.

Authors:  Aistė Kondrotienė; Albertas Daukša; Daina Pamedytytė; Mintautė Kazokaitė; Aurelija Žvirblienė; Dalia Daukšienė; Vaida Simanavičienė; Raimonda Klimaitė; Ieva Golubickaitė; Rytis Stakaitis; Valdas Šarauskas; Rasa Verkauskienė; Birutė Žilaitienė
Journal:  Diagnostics (Basel)       Date:  2021-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.